BioXcel Therapeutics, Inc. short interest in 2025
In 2025, BioXcel Therapeutics, Inc.'s disclosed short interest ran from 3.74% of shares outstanding on 15 Jan 2025 to 4.71% on 31 Dec 2025, a change of +0.97 percentage points. The year's high was 10.92% on 30 Sep 2025 and its low 2.44% on 15 May 2025, averaging 6.42% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.24 days on 31 Dec 2025. Full history: BioXcel Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 3.74% (15 Jan 2025)
- End of year
- 4.71% (31 Dec 2025)
- Change
- +0.97 pp
- High
- 10.92% (30 Sep 2025)
- Low
- 2.44% (15 May 2025)
- Average
- 6.42%
- Highest days to cover
- 2.24 (31 Dec 2025)
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 3.74% | 1.00 | |
| 31 Mar 2025 | 4.06% | 1.00 | |
| 15 May 2025 | 2.44% | 1.13 | |
| 13 Jun 2025 | 5.79% | 1.48 | |
| 30 Jun 2025 | 6.13% | 1.00 | |
| 15 Jul 2025 | 6.42% | 1.00 | |
| 31 Jul 2025 | 4.84% | 1.00 | |
| 15 Aug 2025 | 10.42% | 1.00 | |
| 15 Sep 2025 | 9.92% | 1.00 | |
| 30 Sep 2025 | 10.92% | 1.14 | |
| 15 Oct 2025 | 7.84% | 1.00 | |
| 31 Oct 2025 | 9.63% | 1.78 | |
| 14 Nov 2025 | 7.23% | 2.21 | |
| 28 Nov 2025 | 4.16% | 1.33 | |
| 15 Dec 2025 | 4.48% | 2.05 | |
| 31 Dec 2025 | 4.71% | 2.24 |
See also: BioXcel Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.